Clinical trial
Budesonide in Treating Patients With Lung Nodules at High Risk of Developing…
NCT00321893 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00321893 |
|---|---|
| Title | Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer |
| Official title | Randomized Phase II Trial of Budesonide Turbuhaler® 800 Micrograms/Twice Daily Versus Placebo in High-Risk Population With Undetermined Lung Nodules Detected at Screening Low Dose CT Scan |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Other |
| Interventions | Budesonide, Placebo |
| Enrollment | 225 |
| Start date | Jan 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | May 4, 2006 |
| Last update posted | Jan 25, 2016 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: